Immunotech Laboratories, Inc. Stock Price

OTCPK:IMMB Community·US$57.5k Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

IMMB Share Price Performance

US$0.0001

-0.00 (-0.99%)

US$0.0001

-0.00 (-0.99%)

US$0.0001

Sun, 9 Nov 25

Share PriceUS$0.0001

IMMB Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks

0 Rewards

View Full Analysis

Immunotech Laboratories, Inc. Key Details

Last Reported Earnings

Dec 31, 2009

Next Reporting Earnings

n/a

: 0
: 0%
: 0%
: 0%

View Full Analysis

About IMMB

Founded: n/a
Employees: n/a
CEO: n/a
WebsiteView website: www.immunotechlab.com

Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Enzolytics, Inc.